NCT00867438View on ClinicalTrials.gov

Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

133

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Ulcerative Colitis
Interventions
PROCEDURE

Sigmoidoscopy

Sponsors
All Listed Sponsors
lead

Cosmo Technologies Ltd

INDUSTRY

NCT00867438 - Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy | Biotech Hunter | Biotech Hunter